Evolution of virulence factors and defection factor H.pylori among gastrointestinal disease patients in Waist province
Keywords:
pylori, gastric disease, Molecular detection, virulence factor detection factorAbstract
Helicobacter Pylori (H. pylori) infection is the most important factor affecting clinical outcome in patients with gastric mucosal lesions The aim of this study is to employ conventional PCR to determine the presence of Helicobacter pylori through molecular analysis of the 16S rRNA gene. Additionally, the existence of virulence genes, cagA, vacA, IceA, will be investigated. Total sample was 40 positive h. Pylori infection in different stage range from mild until sever or chronic among gastrointestinal disease patient from waist province, the age of participant range from 12 to 62 years attended to gastrointestinal section in AL-karma testing hospital during 2022/2023. saliva spacemen was collected to Primers of Polymerase Chain Reaction (PCR) for detection of 16sRNA, CagA,and VagA sl/s2 as a detection and virulence factor of h.pylori infection. The study found 16sRNA positive 40(100%), and CagA most of samples positive 23(57.5%), and the negative 17(42.5%), and the distribution of gastroenteritis patients according to VagA sl/s2 most of samples negative 32(80%) compare to positive 8(20%). there is no significant relationship between CagA (p=0.288) and VagA sl/s2 (p=0.825) tests when considering different age groups, the PCR product for 16sRNA showing difference in nine cases from all positive patients at line 446 bp, that equal to (22.5%) have deferent strain of H. Pylori and the PCR product for CagA showing difference in seven cases from all positive patients at line 599 bp that means 30.4% suffer from sever H. Pylori conclusion : One of fourth of H. Pylori infection have a chance to sever or chronic disease through presence of, CagA, and VagA sl/s2 gene in strain and female’s patients has more risk to suffer from sever H. Pylori infection through change in CagA gene.
Downloads
References
Zamani M., Ebrahimtabar F., Zamani V., Miller W.H.,
Alizadeh-Navaei R.( Shokri-Shirvani J., Derakhshan M.H.
Systematic review with meta-analysis: The worldwide
prevalence of Helicobacter pylori infection. Aliment.
Pharmacol. Ther. 2018;47:868-876. doi:
O.1111/apt.14561. [PubMed] rCrossRef] [Google Scholar]
Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E.,
Tanyingoh D.( Malfertheiner P.( Graham D.Y., Wong
V.W.S., Wu J.C.Y., et al. Global Prevalence of Helicobacter
pylori Infection: Systematic Review and Meta-Analysis.
Gastroenterology. 2017;153:420-429. doi:
1053/j.gastro.2017.04.022. [PubMed]
rCrossRef] [Google Scholar]
. Salama N.R., Hartung M., Muller A. Life in the human
stomach: Persistence strategies of the bacterial
pathogen Helicobacter pylori. Nat. Rev. Microbiol.
;11:385-399. doi: 10.1038/nrmicro3016. [PMC free
article] [PubMed] [CrossRef] [Google Scholar]
Wen S., Moss S. Helicobacter pylori virulence factors in
gastric carcinogenesis. Cancer Lett. 2009;282:1-8. doi:
1016/j.canlet.2008.11.016. [PMC free article]
[PubMed] [CrossRef] [Google Scholar]
Nahid-Samiei M., Rahimian G., Shafigh M.( Taheri F.,
Karami-Hurestani M.( Sanaei M.J., Heshmati M.,
Bagheri N. Enhanced Freguency of CD19(+)IL-10(+)B
Cells in Human Gastric Mucosa Infected by Helicobacter
pylori. Am. J. Med. Sci. 2020;359:347-353.
doi:1O.1O16/j.amjms.2O2O.O3.O19. [PubMed]
[CrossRef] [Google Scholar]
Sanaii A., Shirzad H., Haghighian M., Rahimian G.( Soltani
A., Shafigh M., Tahmasbi K., Bagheri N. Role of Th22
cells in Helicobacter pylori—Related gastritis and peptic
ulcer diseases. Mol. Biol. Rep. 2019;46:5703-5712. doi:10.1007/s11033-019-05004-1. [PubMed!
[CrossRef] [Google Scholar]
Reyes VE. Helicobacter pylori and Its Role in Gastric
Cancer. Microorganisms. 2023 May 17;11(5):1312.
Moaddeb A, Fattahi MR, Firouzi R, Derakhshandeh A,
Farshad S. Genotyping of the Helicobacter
pyloricagA gene isolated from gastric biopsies in Shiraz,
Southern Iran: a PCR-RFLP and sequence analysis
approach. Jundishapur J Microbiol
;9:e30046.10.5812/ijm.30046Search in Google
ScholarPubMed PubMed Central
Lin CW, Wang SF, Cheng KS. Genotyping
of Helicobacter pylori isolates by random amplified
polymorphic DNA and polymerase chain reaction¬
restriction fragment length polymorphism. M Taiwan J
Med 1998;3:101.Search in Google Scholar
Queiroz DM, Dani R, Silva LD, Santos A, Moreira LS,
Rocha GA, et al. Factors associated with treatment
failure of Helicobacter pylori infection in a developing
country. J Clin Gastroenterol 2OO2;35:315-
10.1097/00004836-200210000-00007Search in
Google Scholar
Brenner H, Bode G, Boeing H.Helicobacter pyloriinfection
among offspring of patients with stomach cancer.
Gastroenterology 2OOO;H8:31-5.1O.1O16/SOO16-
(00)70411-2Search in Google ScholarPubMed
Reshetnyak VI, Burmistrov Al, Maev IV. Helicobacter pylori:
Commensal, symbiont or pathogen?. World journal of
gastroenterology. 2021 Feb 2;27(7):545.
Trang T.T.H., Binh T.T., Yamaoka Y. Relationship between
vacA Types and Development of Gastroduodenal
Diseases. Toxins. 2016;8:182.
doi:10.3390/toxins8060182. [PMC free
article] [PubMed] [CrossRef] [Google Scholar]
Ohnishi N., Yuasa H., Tanaka S., Sawa H., Miura M.,
Matsui A., Higashi H., Musashi M., Iwabuchi K., Suzuki
M., et al. Transgenic expression of Helicobacter
pylori CagA induces gastrointestinal and hematopoietic
neoplasms in mouse. Proc. Natl. Acad. Sci.
USA. 2008;105:1003-1008.
doi: 1O.1O73/pnas.O7111831O5. [PMC free
article] [PubMed] [CrossRef] [Google Scholar]
Leja M., Grinberga-Derica I., Bilgilier C., Steininger C.
Review: Epidemiology of Helicobacter pylori infection.
Helicobacter. 2019;24((Suppl. 1)):e12635. doi:
1111/hel.12635. [PubMed] [CrossRef] [Google Scholar]
lO.Thung I., Aramin H., Vavinskaya V., Gupta S., Park J.Y.,
Crowe S.E., Valasek M.A. Review article: The global
emergence of Helicobacter pylori antibiotic
resistance. Aliment. Pharmacol. Then 2016;43:514-533.
doi:10.1111/apt.13497. [PMC free article [PubMed]
[CrossRef [Google Scholar]
Camargo M.C., Garcia A., Riquelme A., Otero W.,
Camargo C.A., Hernandez-Garcia T., Candia R., Bruce
M.G., Rabkin C.S. The problem of Helicobacter
pylori resistance to antibiotics: A systematic review in
Latin America. Am. J. Gastroenterol. 2014;109:485-495.
doi: 10.1038/ajg.2014.24. [PMC free article] [PubMed]
[CrossRef] [Google Scholar]
Bujanda L., Nyssen O.P., Vaira D., Saracino I.M., Fiorini
G., Lerang F., Georgopoulos S., Tepes B., Heluwaert F.,
Gasbarrini A., et al. Antibiotic Resistance Prevalence
and Trends in Patients Infected with Helicobacter
pylori in the Period 2013-2020: Results of the European
Registry on H. pylori Management (HpEuReg) Antibiotics. 2O21;1O:1O58.
doi:10.3390/antibiotics10091058.[PMC free article]
[PubMed] [CrossRef] [Google Scholar]
Megraud F., Bruyndonckx R., Coenen S., Wittkop L.,
Huang T.D., Hoebeke M., Benejat L., Lehours P.,
Goossens H., Glupczynski Y., et al. Helicobacter
pylori resistance to antibiotics in Europe in 2018 and its
relationship to antibiotic consumption in the
community. Gut. 2021;70:1815-1822. doi:10.1136/gutjnl-
-324032. [PubMed] [CrossRef] [Google Scholar]
Malespin-Bendana W, Ferreira RM, Pinto MT, Figueiredo C,
Alpizar-Alpizar W, Une C, Figueroa-Protti L, Ramirez V.
H elicobacter pylori infection induces abnormal
expression of pro-angiogenic gene ANGPT2 and miR-
a in AGS gastric cell line. Brazilian Journal of
Microbiology. 2023 Mar 6:1-1.
Wei GC, Chen J, Liu AY, Zhang M, Liu XJ, Liu D, Xu J, Liu
BR, Ling H, Wu HX, Du YJ. Prevalence of Helicobacter
pylori vacA, cagA and iceA genotypes and correlation
with clinical outcome. Experimental and therapeutic
medicine. 2012 Dec 1;4(6):1039-44.
Moaddeb A, Fattahi MR, Firouzi R, Derakhshandeh A,
Farshad S. Genotyping of the Helicobacter pylori cagA
gene isolated from gastric biopsies in Shiraz, Southern
Iran: a PCR-RFLP and sequence analysis approach.
Jundishapur journal of microbiology. 2016 Apr;9(4).
. Idowu A., Mzukwa A., Harrison U., Palamides P., Haas R.,
Mbao M., Mamdoo R., Bolon J., Jolaiya T., Smith S., et
al. Detection of Helicobacter pylori and its virulence
genes (cagA, dupA, and vacA) among patients with
gastroduodenal diseases in Chris Hani Baragwanath
Academic Hospital, South Africa. BMC Gastroenterol.
;19:73. doi: 10.1186/s12876-019-0986-0. [PMC free
article] [PubMed] [CrossRef] [Google Scholar]
.Oktem-Okullu S., Cekic-Kipritci Z., Kilic E., Seymen N.,
Mansur-Ozen N., Sezerman U., Gurol Y. Analysis of
Correlation between the Seven Important Helicobacter
pylori (H. pylori) Virulence Factors and Drug Resistance
in Patients with Gastritis. Gastroenterol. Res. Pract.
;2020:3956838. doi: 10.1155/2020/3956838. [PMC
free article] [PubMed] [CrossRef] [Google Scholar]
.Alarcon-Millan J., Fernandez-Tilapa G., Cortes-Malagon
E.M., Castanon-Sanchez C.A., De Sampedro-Reyes J.,
Cruz-Del Carmen I., Betancourt-Linares R., RomanRoman A. Clarithromycin resistance and prevalence
of Helicobacter pylori virulent genotypes in patients
from Southern Mexico with chronic gastritis. Infect.
Genet. Evol. 2016;44:190-198.
doi:10.1016/j.meegid.2016.06.044. [PubMed]
[CrossRef] [Google Scholar]
. Martinez-Carrillo D.N., Atrisco-Morales J., HernandezPando R., Reyes-Navarrete S., Betancourt-Linares R.,
Cruz-del Carmen I., Illades Aguiar B., Roman-Roman A.,
Fernandez-Tilapa G. Helicobacter pylori vacA and cagA
genotype diversity and interferon gamma expression in
patients with chronic gastritis and patients with gastric
cancer. Rev. Gastroenterol. Mex. 2014;79:220-228. doi:
1016/j.rgmxen.2014.12.001. [PubMed] [CrossRef]
[Google Scholar]
. Roman-Roman A., Martinez-Carrillo D.N., Atrisco-Morales J.,
Azucar-Heziquio J.C., Cuevas-Caballero A.S., CastanonSanchez C.A., Reyes-Rios R., Betancourt-Linares R., ReyesNavarrete S., Cruz-Del Carmen I., et al. Helicobacter
pylori vacA s1m1 genotype but not cagA or babA2 increase
the risk of ulcer and gastric cancer in patients from
Southern Mexico.Gut Pathog. 2017;9:18.doi:10.1186/s13099-017-0167-z. [PMC free
article] [PubMed] [CrossRef] [Google Scholar]
. Li Y., Lin R., Jin Y., Jin S., Chen B., Wu X. Genotyping
Helicobacter pylori antibiotic resistance and virulenceassociated genes in patients with gastric cancer in
Wenzhou, China. Arab. J. Gastroenterol. 2O21;22:267-
doi: 10.1016/j.ajg.2021.05.017. [PubMed]
[CrossRef] [Google Scholar]
. Nguyen T.H., Ho T.T.M., Nguyen-Hoang T.P., Gumar S.,
Pham T.T.D., Bui G.N., Bulach D., Nguyen T.V., Rahman
M. The endemic Helicobacter pylori population in
Southern Vietnam has both South East Asian and
European origins. Gut Pathog. 2O21;13:57. doi:
O.1186/s13O99-O21-OO452-2.[PMC free
article] [PubMed] [CrossRef] [Google Scholar]
. Fernandez-Reyes M.M., Tamayo E., Rojas-Rengifo D.,
Fischer W., Carrasco-Garcia E., Alonso M., Lizasoain J.,
Bujanda L., Cosme A., Montes M. Helicobacter
pylori pathogenicity and primary antimicrobial
resistance in Northern Spain. Eur. J. Clin. Invest.
;49:e13150. doi: 1O.1111/eci.1315O. [PubMed]
[CrossRef] [Google Scholar]
. Yin L., Liu F., Guo C., Wang Q., Pan K., Xu L., Xiong Y.,
Chen Y., Chen Z. Analysis of virulence diversity of
Helicobacter pylori strains isolated in Guizhou
province, China. Mol. Med. Rep. 2018;18:4611-4620.
doi:10.3892/mmr.2018.9462. [PubMed]
[CrossRef] [Google Scholar]
. Queiroz D.M., Silva C.I., Goncalves M.H., Braga-Neto M.B.,
Fialho A.B., Fialho A.M., Rocha G.A., Rocha A.M., Batista
S.A., Guerrant R.L., et al. Higher freguency of cagA
EPIYA-C phosphorylation sites in H. pylori strains from
first-degree relatives of gastric cancer patients. BMC
Gastroenterol. 2012,-12:107. doi:10.1186/1471-230X-12-
[PMC free article] [PubMed] [CrossRef] [Google
Scholar]
. Secka O., Antonio M., Berg D.E., Tapgun M., Bottomley C.,
Thomas V., Walton R., Corrah T., Thomas J.E., Adegbola
R.A. Mixed infection with cagA positive and cagA negative
strains of Helicobacter pylori lowers disease burden in The
Gambia. PLoS ONE. 2011;6:e27954. doi:
1371/journal.pone.0027954. [PMC free article] [PubMed]
[CrossRef] [Google Scholar]
. Lopez-Vidal Y., Ponce-de-Leon S., Castillo-Rojas G.,
Barreto-Zuniga R., Torre-Delgadillo A. High diversity of
vacA and cagA Helicobacter pylori genotypes in
patients with and without gastric cancer. PLoS ONE. 2008;3: e3849. Doi: 10.1371/journal.pone.0003849. [PMC free article] [PubMed] [Cross Ref] [Google Scholar]
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.